This inventor holds 1 USPTO granted patent. Top assignee: Universität De Barcelona. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Talía Velasco Hernández: Innovator in B-Cell Acute Lymphoblastic Leukemia Treatment
Introduction
Talía Velasco Hernández is a prominent inventor based in Badalona, Spain. He has made significant contributions to the field of medical research, particularly in the treatment of B-cell acute lymphoblastic leukemia (B-ALL). His innovative approach has led to the development of a unique patent that addresses this critical health issue.
Latest Patents
Talía holds a patent titled "CD22 TARGETING-MOIETY FOR THE TREATMENT OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)." This patent represents a significant advancement in targeted therapies for leukemia, showcasing his commitment to improving patient outcomes.
Career Highlights
Talía is affiliated with the University of Barcelona, where he conducts research and collaborates with other experts in the field. His work has been instrumental in advancing the understanding and treatment of B-ALL, making him a valuable asset to the medical community.
Collaborations
He has worked alongside notable colleagues, including Pablo Menéndez Buján and Samanta Romina Zanetti. Their combined expertise has fostered a collaborative environment that enhances the research and development of innovative treatments.
Conclusion
Talía Velasco Hernández is a dedicated inventor whose work in leukemia treatment exemplifies the impact of innovation in medicine. His contributions continue to inspire advancements in healthcare and improve the lives of patients battling B-ALL.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile